In March 2012, the SAGE Working Group on Vaccine Hesitancy was convened to define the term “vaccine hesitancy”, as well as to map the determinants of vaccine hesitancy and develop tools to measure and address the nature and scale of hesitancy in settings where it is becoming more evident.
Read moreRelated content

This report uses VCP data from 2015 – May 2021 to assess local barriers and drivers to adult vaccine uptake in Low – Middle Income Countries, with a view to supporting the development of targeted interventions and programs.

The primary aims of this systematic review are to: 1) identify research…

The IRIS Academic Research Group was founded by some of the world’s leading researchers and academic institutions and launched in June 2021 at the inaugural Global Vaccine Confidence Summit as part of the UK government’s G7 Presidency.

The Vaccine Confidence Project™ is a WHO Centre of Excellence on addressing Vaccine Hesitancy, and is engaged in many strands of research pertaining to vaccine hesitancy.

When the term ‘vaccine hesitancy’ first appeared, it was deemed ambiguous and difficult to measure.

To identify knowledge gaps, beliefs and attitudes in relation to the COVID-19 pandemic and COVID-19 vaccine acceptance among adults in the Asia-Pacific region, the Vaccine Confidence Project conducted two waves of quantitative research in 2021 and 2022.